Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy. (Record no. 4391)

MARC details
000 -LEADER
fixed length control field 02088nam a22003497a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190621s20132013 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2157-7005
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 24147238
245 ## - TITLE STATEMENT
Title Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy.
251 ## - Source
Source American journal of perinatology reports. 3(2):71-4, 2013 Oct.
252 ## - Abbreviated Source
Abbreviated source Am. j. perinatol. reports. 3(2):71-4, 2013 Oct.
253 ## - Journal Name
Journal name AJP reports
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2013
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2014
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
266 ## - Date added to catalog
Date added to catalog 2019-06-21
520 ## - SUMMARY, ETC.
Abstract Background Pulmonary arterial hypertension carries a high risk of mortality in pregnancy. Recent advances in treatment may improve disease course and allow for successful management of the pregnancy. Case Report We present the case of a 20-year-old gravida 1, para 0 with diagnosis of severe primary pulmonary hypertension. The patient was managed with epoprostenol (prostacyclin) infusion via an indwelling catheter, which was initiated at 23 weeks' gestation. The dose was adjusted to the patient's symptoms and a successful vaginal delivery was achieved at 36 weeks' gestation. Although maternal postpartum course was uncomplicated, unexplained neonatal demise occurred at 11 days of life. Conclusion Successful management of pulmonary hypertension in pregnancy can be accomplished with a multidisciplinary approach and intensive therapy. Long-term effects of epoprostenol on fetal or neonatal well-being are unknown.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element PubMed-not-MEDLINE -- Not indexed
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Obstetrics and Gynecology/Maternal-Fetal Medicine
657 ## - INDEX TERM--FUNCTION
Medline publication type Case Reports
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Driggers, Rita W
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Fries, Melissa H
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Ruiz, George
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Timofeev, Julia
790 ## - Authors
All authors Driggers RW, Fries M, Ruiz G, Timofeev J
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1055/s-0033-1338169">https://dx.doi.org/10.1055/s-0033-1338169</a>
Public note https://dx.doi.org/10.1055/s-0033-1338169
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 06/21/2019   24147238 24147238 06/21/2019 06/21/2019 Journal Article

Powered by Koha